125 related articles for article (PubMed ID: 2137250)
1. Atriopeptin alters the vasopressin and renin responses elicited by hemorrhage.
Wang BC; Leadley RJ; Goetz KL
Proc Soc Exp Biol Med; 1990 Feb; 193(2):85-91. PubMed ID: 2137250
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal reflexes do not attenuate the renal effects of infused atriopeptin in conscious dogs.
Leadley RJ; Zhu JL
Proc Soc Exp Biol Med; 1992 Oct; 201(1):40-6. PubMed ID: 1388273
[TBL] [Abstract][Full Text] [Related]
3. Effect of hemorrhage on plasma atriopeptin levels in conscious dogs.
Geer PG; Wang BC; Flora-Ginter G; Leadley RJ; Goetz KL
Proc Soc Exp Biol Med; 1988 Mar; 187(3):327-34. PubMed ID: 2964642
[TBL] [Abstract][Full Text] [Related]
4. Natriuresis during atrial distension and a concurrent decline in plasma atriopeptin.
Goetz KL; Wang BC; Bie P; Leadley RJ; Geer PG
Am J Physiol; 1988 Aug; 255(2 Pt 2):R259-67. PubMed ID: 2970235
[TBL] [Abstract][Full Text] [Related]
5. Effects of human atrial natriuretic peptide on renal function and vasopressin release.
Kimura T; Abe K; Shoji M; Tsunoda K; Matsui K; Ota K; Inoue M; Yasujima M; Yoshinaga K
Am J Physiol; 1986 May; 250(5 Pt 2):R789-94. PubMed ID: 2939732
[TBL] [Abstract][Full Text] [Related]
6. Vasoconstriction and hypersensitivity to vasoactive substances after acute volume expansion in dogs.
Otsuka A; Ogihara T; Kohara K; Mikami H; Katahira K; Tsunetoshi T; Kumahara Y
Hypertension; 1988 Jul; 12(1):59-66. PubMed ID: 2456268
[TBL] [Abstract][Full Text] [Related]
7. Enhanced atrial peptide natriuresis during angiotensin and aldosterone blockade in dogs.
Bie P; Wang BC; Leadley RJ; Goetz KL
Am J Physiol; 1990 May; 258(5 Pt 2):R1101-7. PubMed ID: 2140023
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.
Weidmann P; Hellmueller B; Uehlinger DE; Lang RE; Gnaedinger MP; Hasler L; Shaw S; Bachmann C
J Clin Endocrinol Metab; 1986 May; 62(5):1027-36. PubMed ID: 2937799
[TBL] [Abstract][Full Text] [Related]
11. Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog.
Zimmerman RS; Schirger JA; Edwards BS; Schwab TR; Heublein DM; Burnett JC
Circ Res; 1987 Jul; 61(1):63-9. PubMed ID: 2955951
[TBL] [Abstract][Full Text] [Related]
12. Effects of atriopeptin infusion versus effects of left atrial stretch in awake dogs.
Goetz KL; Wang BC; Geer PG; Sundet WD; Needleman P
Am J Physiol; 1986 Feb; 250(2 Pt 2):R221-6. PubMed ID: 2936255
[TBL] [Abstract][Full Text] [Related]
13. The effects of synthetic alpha-human atrial natriuretic peptide (alpha-hANP) on the overall baroreflex system in anesthetized mongrel dogs.
Tateishi J; Mitani Y; Iwasaki T
Clin Exp Hypertens; 1993 Jan; 15(1):15-43. PubMed ID: 8467310
[TBL] [Abstract][Full Text] [Related]
14. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Joyce SL; Gilchrist NL
J Clin Endocrinol Metab; 1986 Oct; 63(4):946-53. PubMed ID: 2943757
[TBL] [Abstract][Full Text] [Related]
15. Long-term hypotensive and renal effects of atrial natriuretic peptide.
Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
[TBL] [Abstract][Full Text] [Related]
16. Effect of vertebral artery infusions of oxytocin on plasma vasopressin concentration, plasma renin activity, blood pressure and heart rate and their responses to hemorrhage.
Brooks DP; Share L; Crofton JT; Rockhold RW; Matsui K
Neuroendocrinology; 1984 May; 38(5):382-6. PubMed ID: 6374492
[TBL] [Abstract][Full Text] [Related]
17. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
Mori K
Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide in patients with essential hypertension. Hemodynamic, renal, and hormonal responses.
Predel HG; Schulte-Vels O; Glänzer K; Meyer-Lehnert H; Kramer HJ
Am J Hypertens; 1991 Nov; 4(11):871-9. PubMed ID: 1665067
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
Kimura T; Abe K; Ota K; Omata K; Shoji M; Kudo K; Matsui K; Inoue M; Yasujima M; Yoshinaga K
J Clin Endocrinol Metab; 1986 May; 62(5):1003-10. PubMed ID: 2937798
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs.
Bie P; Wang BC; Leadley RJ; Goetz KL
Am J Physiol; 1988 Feb; 254(2 Pt 2):R161-9. PubMed ID: 2964204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
